Joan Bladé

Amyloidosis Foundation — United States

Medicine · Health Sciences

101h-index52.8kcitations759works1.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Multiple Myeloma Research and Treatments(634), Protein Degradation and Inhibitors(221), Peptidase Inhibition and Analysis(135), Cancer Treatment and Pharmacology(121), Amyloidosis: Diagnosis, Treatment, Outcomes(84)

Publications757 total

B01 | ANALYSIS OF SUSTAINED MINIMAL RESIDUAL DISEASE NEGATIVITY IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA TREATED WITH CARFILZOMIB-LENALIDOMIDE-DEXAMETHASONE WITH OR WITHOUT ISATUXIMAB (PHASE III ISKIA TRIAL)
Haematologica·2025Open Access
Supplementary Figure 7 from Bicistronic CAR T Cell against BCMA and CD229 Effectively Controls Myeloma Even When BCMA Expression Is Limited
2025Open Access
Supplementary Table 3 from Bicistronic CAR T Cell against BCMA and CD229 Effectively Controls Myeloma Even When BCMA Expression Is Limited
2025Open Access
Supplementary Figure 5 from Bicistronic CAR T Cell against BCMA and CD229 Effectively Controls Myeloma Even When BCMA Expression Is Limited
2025Open Access
Supplementary Figure 9 from Bicistronic CAR T Cell against BCMA and CD229 Effectively Controls Myeloma Even When BCMA Expression Is Limited
2025Open Access
Supplementary Figure 6 from Bicistronic CAR T Cell against BCMA and CD229 Effectively Controls Myeloma Even When BCMA Expression Is Limited
2025Open Access
Supplementary Figure 12 from Bicistronic CAR T Cell against BCMA and CD229 Effectively Controls Myeloma Even When BCMA Expression Is Limited
2025Open Access
Supplementary Figure 8 from Bicistronic CAR T Cell against BCMA and CD229 Effectively Controls Myeloma Even When BCMA Expression Is Limited
2025Open Access
Data from Bicistronic CAR T Cell against BCMA and CD229 Effectively Controls Myeloma Even When BCMA Expression Is Limited
2025Open Access
Supplementary Figure 3 from Bicistronic CAR T Cell against BCMA and CD229 Effectively Controls Myeloma Even When BCMA Expression Is Limited
2025Open Access
Supplementary Figure 10 from Bicistronic CAR T Cell against BCMA and CD229 Effectively Controls Myeloma Even When BCMA Expression Is Limited
2025Open Access
Supplementary Figure 2 from Bicistronic CAR T Cell against BCMA and CD229 Effectively Controls Myeloma Even When BCMA Expression Is Limited
2025Open Access
Supplementary Figure 4 from Bicistronic CAR T Cell against BCMA and CD229 Effectively Controls Myeloma Even When BCMA Expression Is Limited
2025Open Access
Supplementary Figure 1 from Bicistronic CAR T Cell against BCMA and CD229 Effectively Controls Myeloma Even When BCMA Expression Is Limited
2025Open Access
Supplementary Tables 1-2 from Bicistronic CAR T Cell against BCMA and CD229 Effectively Controls Myeloma Even When BCMA Expression Is Limited
2025Open Access
Supplementary Figure 11 from Bicistronic CAR T Cell against BCMA and CD229 Effectively Controls Myeloma Even When BCMA Expression Is Limited
2025Open Access
Assessing the Clinical Implications and Prognostic Value of Light-Chain N-Glycosylation in 781 Multiple Myeloma Patients at Diagnosis
Clinical Lymphoma Myeloma & Leukemia·2025
Characteristics of Long-Term Survivors in Multiple Myeloma: Exploring Factors for Cure After Extended Follow-Up
Clinical Lymphoma Myeloma & Leukemia·2025
High Accuracy of Next-Generation Flow (NGF) in Predicting Measurable Residual Disease by Next-Generation Sequencing (NGS) in the 10−6 Range: A Prospective Comparison Within the Phase III IsKia Trial
Clinical Lymphoma Myeloma & Leukemia·2025
Measurable Residual Disease (MRD) Dynamics Reveals a Therapeutic Vulnerability State for Early Immunotherapy Interception in Multiple Myeloma (MM)
Clinical Lymphoma Myeloma & Leukemia·2025
page 1 of 38Next →

Frequent Co-authors

Jesús F. San Miguel(33), Pieter Sonneveld(23), Michèle Cavo(20), Meletios Α. Dimopoulos(19), Paul G. Richardson(19), Brian G.M. Durie(18), Mario Boccadoro(16), Heinz Ludwig(16), Antonio Palumbo(15), Juan José Lahuerta(15), Kenneth C. Anderson(15), María‐Victoria Mateos(14), Sagar Lonial(14), Laura Rosiñol(14), Philippe Moreau(14), S. Vincent Rajkumar(13), Orhan Sezer(12), Hartmut Goldschmidt(11), Robert A. Kyle(11), Robert Z. Orlowski(10)